Specialized Amino Acid Derivatives and Inborn Errors of Metabolism)

0.0(0)
Studied by 1 person
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/21

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 12:52 AM on 9/13/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

22 Terms

1
New cards

Tryptophan

Key Biological Derivatives: Niacin (Vitamin B3), Serotonin, Melatonin

Board Exam Significance: A deficiency in tryptophan absorption causes a Niacin deficiency, leading to Pellagra

2
New cards

Tyrosine

Key Biological Derivatives: Catecholamines (Dopamine Norepinephrine Epinephrine), Melanin, Thyroxine (T4/T3)

Board Exam Significance: Derived from Phenylalanine. Deficiencies in the enzymes handling Tyrosine lead to severe metabolic diseases (Albinism, Alkaptonuria).

3
New cards

Glutamate

Key Biological Derivatives: GABA (Gamma-aminobutyric acid), Glutathione

Board Exam Significance: ‘blank’ is the primary excitatory neurotransmitter, but it decarboxylates into GABA, the primary inhibitory neurotransmitter.

4
New cards

Histidine

Key Biological Derivatives: Histamine

Board Exam Significance: Requires Vitamin B6 as a cofactor for decarboxylation. Major mediator of allergic responses and gastric acid secretion

5
New cards

Arginine

Key Biological Derivatives: Nitric Oxide (NO), Urea, Creatine

Board Exam Significance: Nitric Oxide is a potent vasodilator synthesized by NO Synthase (NOS).

6
New cards

Glycine

Key Biological Derivatives: Porphyrin (Heme), Purines, Glutathione

Board Exam Significance: Glycine is the most basic amino acid and acts as an inhibitory neurotransmitter in the spinal cord.

7
New cards

Glutathione (GSH)

A tripeptide formed from Glutamate, Cysteine, and Glycine. It is the body's master intracellular antioxidant. It protects red blood cells from oxidative damage (hydrogen peroxide) by oxidizing its sulfhydryl (—SH) group to form a disulfide bond (GSSG).

8
New cards

Neuropeptides (Substance P & Endorphins)

  • Substance P: An 11-amino-acid peptide that transmits pain signals from the periphery into the central nervous system.

  • Endorphins & Enkephalins: Endogenous opioid peptides that bind to the same receptors as morphine. They act as natural painkillers by inhibiting the release of Substance P.


9
New cards

Insulin

Contains 51 amino acids organized into an A-chain and a B-chain connected by disulfide bridges.

10
New cards

Oxytocin & Vasopressin (ADH)

Nonapeptides (9 amino acids) secreted by the posterior pituitary. Structurally, they differ by only two amino acids but have vastly different functions (uterine contraction vs. water retention).

11
New cards

Hartnup Disease

  • Defect: Autosomal recessive mutation in the transport proteins for neutral amino acids (especially Tryptophan) in the renal tubules and intestinal epithelium.

  • Mechanism: The body cannot absorb Tryptophan. Since Tryptophan is the precursor for Niacin (Vitamin B3), the patient develops a severe Niacin deficiency.


12
New cards

Phenylketonuria (PKU)

  • Defect: Deficiency of the enzyme Phenylalanine Hydroxylase (or its cofactor BH4).

  • Mechanism: The body cannot convert Phenylalanine into Tyrosine. Phenylalanine accumulates and converts into toxic phenylketones, which damage the developing brain. Tyrosine becomes an essential amino acid because the body can no longer synthesize it.


13
New cards

Albinism

  • Defect: Deficiency in the enzyme Tyrosinase.

  • Mechanism: The body cannot convert Tyrosine into Melanin (the pigment responsible for skin, hair, and eye color).


14
New cards

Alkaptonuria (Black Urine Disease)

  • Defect: Deficiency of Homogentisate oxidase (an enzyme in the Tyrosine degradation pathway).

  • Mechanism: Homogentisic acid accumulates in the blood and tissues.


15
New cards

Hartnup Disease: Clinical Presentation

Pellagra-like symptoms (The 3 Ds: Dermatitis, Diarrhea, Dementia).

16
New cards

Phenylketonuria (PKU): Clinical Presentation

Severe intellectual disability, microcephaly, hypopigmentation (light skin/hair, due to lack of Tyrosine for melanin), and a characteristic "musty" or "mousy" body odor.

Management: Strict lifelong restriction of dietary Phenylalanine (avoiding the artificial sweetener Aspartame).

17
New cards

Albinism: Clinical Presentation

Lack of pigmentation, severe photosensitivity, and increased risk of skin cancers (squamous and basal cell carcinomas).

18
New cards

Alkaptonuria (Black Urine Disease): Clinical Presentation

The hallmark sign is urine that turns black upon standing (oxidation in the air). It also causes bluish-black pigmentation of cartilage (ochronosis) and early-onset debilitating arthritis.

19
New cards

Maple Syrup Urine Disease (MSUD)

A dangerous metabolic disorder affecting the branched-chain amino acids (BCAAs)

  • Deficient Enzyme: Branched-chain alpha-ketoacid dehydrogenase (requires Vitamin B1 / Thiamine as a cofactor).

  • Accumulated Amino Acids: Leucine, Isoleucine, and Valine (and their corresponding alpha-ketoacids).

PhLE Mnemonic: "I Love Vermont maple syrup" (Isoleucine, Leucine, Valine).

20
New cards

Homocystinuria

A disorder of methionine metabolism that presents somewhat similarly to Marfan syndrome.

  • Deficient Enzyme: Most commonly Cystathionine beta-synthase (requires Vitamin B6 / Pyridoxine as a cofactor).

  • Accumulated Substance: Homocysteine and Methionine.


21
New cards

Maple Syrup Urine Disease: clinical hallmarks

  • Sweet, maple syrup-smelling urine (caused by the accumulation of isoleucine).

  • Severe central nervous system defects, intellectual disability, and death if untreated.

Management: Dietary restriction of BCAAs.

22
New cards

Homocystinuria: Clinical Hallmarks

  • Marfanoid habitus: Tall, thin stature with long extremities and arachnodactyly (spider-like fingers).

  • Downward lens subluxation in the eyes (unlike Marfan syndrome, which is usually upward).

  • High risk of early, severe cardiovascular thrombosis (blood clots), which is the leading cause of early death.